(Press-News.org) WEST LAFAYETTE, Ind. - New technology from Purdue University innovators may help improve tissue restoration outcomes for people with breast cancer and other diseases or traumatic injuries.
Purdue researchers, along with fellowship-trained breast surgeon Carla Fisher of Indiana University School of Medicine, teamed up with Purdue startup GeniPhys to develop and perform preclinical studies on a regenerative tissue filler.
This is a first-of-a-kind, in situ scaffold-forming collagen. When applied as a filler for soft tissue defects and voids, it shows promise for accelerating and improving tissue restoration outcomes. The team's work is published in Scientific Reports.
"It would assist in maintaining the quality of life and emotional well-being of millions of breast cancer survivors each year worldwide," said Sherry Harbin, a professor in Purdue's Weldon School of Biomedical Engineering.
The innovators in Harbin's lab designed and patented the collagen polymer used for this technology. A video of the technology is available here. Harbin founded GeniPhys, a Purdue startup focused on the commercialization of the collagen polymer technology.
"Such an approach may also benefit other patient populations in need of soft tissue restoration or reconstruction, including children with congenital defects, individuals with difficult-to-heal skin ulcers, individuals suffering from traumatic injuries and cancer patients requiring resection of tumors within tissues other than breast."
A National Science Foundation SBIR Phase I award to GeniPhys supported the preclinical validation studies performed by the team, which included biomedical engineers from Purdue's Weldon School and a fellowship-trained breast surgeon from Indiana University School of Medicine. Jeannie Plantenga and Abigail Cox from Purdue's College of Veterinary Medicine also were part of the team.
The regenerative tissue filler, when applied to breast tissue voids, such as those associated with breast conserving surgery, restored breast shape and consistency and supported new breast tissue formation over time, including mammary glands, ducts and adipose tissue. The filler also helped avoid wound contraction and scar formation, which can be painful for patients and contribute to breast deformities.
This filler represents a highly purified liquid collagen protein, that when brought to physiologic conditions by mixing with a proprietary buffer, can be applied to tissue voids. The liquid collagen conforms to patient-specific void geometries and then undergoes a self-assembly reaction to form a fibrillar collagen scaffold like those that make up the body's tissues.
This scaffold has soft tissue consistency and persists, where it induces a regenerative healing response.
"This tissue filler represents the first planned medical product developed using our innovative collagen polymer technology," Harbin said. "This collagen polymer supports custom fabrication of a broad range of collagen materials for various applications including tissue restoration, therapeutic cell and drug delivery, or enhancement of tissue-implantable devices interfaces."
INFORMATION:
The innovators worked with the Purdue Research Foundation Office of Technology Commercialization to patent the technology. The researchers are looking for partners to continue developing and commercializing their technology. For more information on licensing and other opportunities, contact Sherry Harbin at harbins@purdue.edu.
About Purdue Research Foundation Office of Technology Commercialization
The Purdue Research Foundation Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university's academic activities through commercializing, licensing and protecting Purdue intellectual property. The office is located in the Convergence Center for Innovation and Collaboration in Discovery Park District, adjacent to the Purdue campus. In fiscal year 2020, the office reported 148 deals finalized with 225 technologies signed, 408 disclosures received and 180 issued U.S. patents. The office is managed by the Purdue Research Foundation, which received the 2019 Innovation and Economic Prosperity Universities Award for Place from the Association of Public and Land-grant Universities. In 2020, IPWatchdog Institute ranked Purdue third nationally in startup creation and in the top 20 for patents. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Contact otcip@prf.org for more information.
About Purdue University
Purdue University is a top public research institution developing practical solutions to today's toughest challenges. Ranked the No. 5 Most Innovative University in the United States by U.S. News & World Report, Purdue delivers world-changing research and out-of-this-world discovery. Committed to hands-on and online, real-world learning, Purdue offers a transformative education to all. Committed to affordability and accessibility, Purdue has frozen tuition and most fees at 2012-13 levels, enabling more students than ever to graduate debt-free. See how Purdue never stops in the persistent pursuit of the next giant leap at purdue.edu.
Writer: Chris Adam, cladam@prf.org
Source: Sherry Harbin, harbins@purdue.edu
The Acheulean was estimated to have died out around 200,000 years ago but the new findings suggest it may have persisted for much longer, creating over 100,000 years of overlap with more advanced technologies produced by Neanderthals and early modern humans.
The research team, led by Dr Alastair Key (Kent) alongside Dr David Roberts (Kent) and Dr Ivan Jaric (Biology Centre of the Czech Academy of Sciences), made the discovery whilst studying stone tool records from different regions across the world. Using statistical techniques new to archaeological science, the archaeologists and conservation experts were able to reconstruct the end of the Acheulean period and re-map the archaeological record.
Previously, a more rapid shift between the earlier Acheulean stone ...
Most people are probably familiar with the unpleasant feeling of eating overripe or underripe fruit. Those who work in agriculture are tasked with ensuring a timely harvest so that ripeness is at an optimal point when the fruit is sold, both to minimize the amount of fruit that goes to waste and maximize the quality of the final product. To this end, a number of techniques to assess fruit ripeness have been developed, each with their respective advantages and disadvantages depending on the type of produce.
Although biochemical and optical methods exist, mechanical techniques are the most widely used. They indirectly assess ripeness based on the fruit's firmness. In turn, firmness ...
Scientists have discovered a previously unknown breeding site used by the world's rarest seal species.
The Mediterranean monk seal is classified as "endangered", with a total population of about 700.
The new study - by the University of Exeter and the Society for the Protection of Turtles (SPOT) - used camera-traps to confirm breeding in caves in northern Cyprus, with at least three pups born from 2016-19 at one cave.
Only certain caves are suitable for monk seal breeding and resting, so - although the numbers are small - the researchers say urgent action is needed to protect these caves.
"This area of coastline in being developed rapidly, especially for ...
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
Their strong recommendation is based on high certainty evidence from six randomised controlled trials involving over 6,000 participants with and without known exposure to a person with covid-19 infection.
High certainty evidence showed that hydroxychloroquine had no meaningful effect on death and admission to hospital, while moderate certainty evidence showed that hydroxychloroquine had no meaningful effect on laboratory confirmed covid-19 infection and it probably increases the risk of adverse effects.
As such, ...
LOS ANGELES -- COVID-19 has taken a huge medical, emotional and economic toll on Americans. Now, new Keck Medicine of USC research shows that the pandemic may also have harmful indirect consequences.
Alcohol and tobacco sales nationwide rose in the early months of COVID-19, according to a study appearing in the Annals of Internal Medicine today. From April - June 2020, researchers found that sales of these substances increased 34% and 13% respectively when compared to the same months in 2019.
"These are significant jumps, and show that the stress, boredom and loneliness caused by the pandemic may have led to increased alcohol and tobacco ...
GALVESTON, Texas -A team from The University of Texas Medical Branch at Galveston (UTMB) focused on drug addiction research have pioneered a new way to study frustration as a factor in substance use disorders. The study was published in the medical journal Psychopharmacology.
Traditional addiction research has focused on three aspects of substance use disorders: craving, impulsivity, or habit. Scientists hypothesized that a fourth factor, frustration, could also lead to escalation of drug use and addiction.
The Psychopharmacology paper noted that research into the role of frustration and substance use disorders ...
Philadelphia, Pa. -- More than one out of every 10 seniors (10.5%) enrolled in a Medicare Advantage plan, also known as a Medicare managed care option, and living in a rural area, switched to traditional Medicare during 2010-2016. The switch was driven primarily due to low satisfaction with care access, according to a study published this week in Health Affairs from researchers at Drexel University's Dornsife School of Public Health. By contrast, only 1.7% of rural traditional Medicare enrollees made the switch to Medicare Advantage during this period.
The findings, among the first to look ...
Early exposure to tough conditions--particularly warmer waters and nightly swings of low oxygen--could leave lasting scars on oysters' ability to grow meaty tissue. A team of biologists at the Smithsonian Environmental Research Center (SERC) reported the discovery in a new study, published online Feb. 26 in the journal Ecological Applications.
Eastern oysters in Chesapeake Bay live mostly in shallow tributaries. It's a rough environment for shellfish that can't move. During hotter months, oxygen levels can swing drastically, from perfectly healthy ...
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases. These bispecific antibodies, which simultaneously bind to tumor antigens and T cells, cleared cancer cells without damaging healthy cells in mouse tumor models and/or cell culture experiments, across the three studies. The results highlight the therapeutic potential of this antibody type, which - unlike engineered immune cell therapies like CAR T - does not have to ...
In the middle of the Indian Ocean lies some of the last coral reef wilderness on Earth. The Chagos Archipelago, a collection of atolls, including Earth's largest - the Great Chagos Bank- is home to reefs that have been largely undisturbed by humans for the last 50 years. Some estimates indicate the Chagos Archipelago may contain more than half of the healthy coral reefs remaining in the entire Indian Ocean. These reefs are protected both by their remote location, and in one of the world's largest no-take marine reserves--the British Indian Ocean Territory (BIOT) marine protected area.
In 2015, scientists at the Khaled ...
